Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice.

Published in: Journal for immunotherapy of cancer (2021)

This study highlights the potential of NAM+GEM as immunotherapy for advanced pancreatic cancer.

Keyphrases